Revia is the brand name of the medication that contains the active ingredient naltrexone. It is classified as an opioid antagonist used primarily to support the treatment of alcohol use disorder and opioid dependence. Clinically it helps reduce cravings and blocks the euphoric effects of alcohol and opioids thereby supporting abstinence. The drug works by binding to opioid receptors in the brain and preventing endogenous opioids from activating them. This blockade disrupts the reward pathway that normally reinforces substance use and diminishes the reinforcing effects of drinking or drug use. By attenuating these signals the medication can influence physiological processes such as dopamine release and the stress response. The net effect is a gradual normalization of brain chemistry which supports long-term recovery when combined with counseling and support services. Because it does not produce opioid agonist effects it can be used safely in patients who have completed detoxification without causing dependence.

Revia is an opioid receptor antagonist used primarily in the treatment of opioid dependence. It functions by blocking the effects of opioid drugs at the mu receptor. By occupying these receptors without activating them the medication reduces cravings and prevents relapse. This antagonistic action disrupts the reward pathway that is driven by endogenous and exogenous opioids. The blockade of mu receptors leads to decreased perception of pain relief and euphoria associated with opioid use. As a result individuals experience a diminished physiological response to opioids if they are consumed. Revia also helps to normalize brain chemistry that has been altered by chronic opioid exposure. Its pharmacological profile supports its role as a maintenance therapy in opioid substitution programs.

Revia can cause nausea in some patients. It may also lead to headache or dizziness. Some individuals experience fatigue or mild stomach discomfort. Skin reactions such as rash are possible. It can occasionally result in elevated liver enzymes. Patients might notice decreased appetite or mild insomnia. These effects are generally mild and transient.

Common side effects of Revia may include nausea fatigue headache dizziness insomnia and dry mouth. These reactions are generally mild and short lived in most individuals. Variability can occur depending on dosage and personal health factors. Mild elevation of liver enzymes has been observed in a small number of patients and is typically monitored. Most symptoms resolve without medical intervention but persistent or severe discomfort should be noted. Overall the medication is considered safe when used according to prescribed regimens.